Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailRespiratory Syncytial Virus (RSV) Therapeutics Market

Respiratory Syncytial Virus (RSV) Therapeutics Market Strategic Insights: Analysis 2024 and Forecasts 2032

Respiratory Syncytial Virus (RSV) Therapeutics Market by Drug Class (Prophylaxis, Treatment), by End-user (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Forecast 2024-2032

Jul 5 2024
Base Year: 2023
150 Pages
Market Research Future Logo

Respiratory Syncytial Virus (RSV) Therapeutics Market Strategic Insights: Analysis 2024 and Forecasts 2032

Key Insights

The global respiratory syncytial virus (RSV) therapeutics market is anticipated to grow from USD 3.0 billion in 2022 to USD 9.0 billion by 2028, exhibiting a CAGR of 21.2% during the forecast period.Respiratory Syncytial Virus, or RSV, is a widely circulating virus that targets the respiratory system of children all through young adults, though it can infect adults too, especially the elderly and those with a weakened immune system. RSV causes a mild to severe illness, including a cold-like illness and respiratory distress that may lead to bronchiolitis or pneumonia. Prophylactic treatments available for RSV include palivizumab and monoclonal antibodies given in order to prevent severe RSV in some high-risk children and infants, while more recent treatment is in the form of antiviral drugs, also known as direct-acting agents. These therapies seek to alleviate the intensity and duration of symptoms as well as prevent adverse effects. The value of RSV therapeutics is in the fact that it reduces hospitalization and healthcare-related demands within high-risk populations considerably. Additional therapies include growth in monoclonal antibodies and vaccines, which will yield additional and sturdier prevention tactics to further improve patients’ health and deliver a vital weapon for handling this extensively present virus.

Respiratory Syncytial Virus (RSV) Therapeutics Market Research Report - Market Size, Growth & Forecast

Respiratory Syncytial Virus (RSV) Therapeutics Trends

  • Increasing prevalence of RSV infections
  • Growing awareness about RSV and its impact
  • Availability of advanced treatment options

Driving Forces: What's Propelling the Respiratory Syncytial Virus (RSV) Therapeutics Market

  • Rising incidence of RSV infections among infants and elderly
  • Launch of new and more effective RSV therapeutics
  • Government initiatives to promote vaccination against RSV
  • Increased research and development activities in the field

Challenges and Restraints in Respiratory Syncytial Virus (RSV) Therapeutics Market

  • Limited availability of affordable treatment options
  • Lack of awareness about RSV in underdeveloped regions
  • High cost of RSV therapeutics

Emerging Trends in Respiratory Syncytial Virus (RSV) Therapeutics

  • Development of monoclonal antibodies and other biologics
  • Focus on combination therapies
  • Use of artificial intelligence in RSV diagnosis and treatment

Growth Catalysts in Respiratory Syncytial Virus (RSV) Therapeutics Industry

Respiratory Syncytial Virus (RSV) Therapeutics Market Growth
  • Government support for RSV research and development
  • Partnerships between pharmaceutical companies and academic institutions
  • Growing adoption of RSV vaccines

Market Segmentation: Respiratory Syncytial Virus (RSV) Therapeutics Analysis

Drug Class:

  • Prophylaxis
  • Treatment

End-user:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Leading Players in the Respiratory Syncytial Virus (RSV) Therapeutics Market

  • AstraZeneca (U.K)
  • Bausch Health Companies Inc. (U.S)
  • AbbVie (U.S)
  • Johnson and Johnson Services Inc. (U.S)
  • Sanofi (France)
  • Merck & Co., Inc. (U.S)
  • Celltrion Inc. (South Korea)
  • mAbxience (Spain)
  • Enanta Pharmaceuticals, Inc (U.S)

Significant developments in Respiratory Syncytial Virus (RSV) Therapeutics Sector

  • Approval of Synagis (palivizumab) for RSV prophylaxis in 1998
  • Launch of Nirsevimab (Beyfortus) in 2023 as the first RSV prophylactic for older adults

Comprehensive Coverage Respiratory Syncytial Virus (RSV) Therapeutics Market Report

  • Market size and forecast
  • Competitive landscape
  • Growth drivers and challenges
  • Porter's Five Forces Analysis
  • SWOT Analysis
  • PESTLE Analysis
  • Value chain analysis
  • Key market trends

Regional Insight

Respiratory Syncytial Virus (RSV) Therapeutics Market Regional Share
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

DROCT

The report provides a detailed analysis of the Respiratory Syncytial Virus (RSV) Therapeutics market, covering key market trends, drivers, restraints, challenges, and opportunities.

Pricing Analysis

The report includes an in-depth analysis of the pricing strategies adopted by key players in the Respiratory Syncytial Virus (RSV) Therapeutics market.

Import And Export Analysis

The report provides an analysis of the import and export trends of Respiratory Syncytial Virus (RSV) Therapeutics in major regions.

Segmentation

The report segments the Respiratory Syncytial Virus (RSV) Therapeutics market by drug class, end-user, and region.

Patent/Trademark Analysis

The report includes an analysis of the patents and trademarks related to Respiratory Syncytial Virus (RSV) Therapeutics.

Respiratory Syncytial Virus (RSV) Therapeutics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 21.2% from 2018-2032
Segmentation
    • By Drug Class
      • Prophylaxis
      • Treatment
    • By End-user
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
  • By Geography
    • By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Increasing Public Awareness for Safer Medicines to Stimulate Market Value
      • 3.3. Market Restrains
        • 3.3.1. Failure of Pipeline Products in Clinical Trials to Hamper Growth
      • 3.4. Market Trends
        • 3.4.1. Manufacturers focusing on the Development of Mitral Valve Product will drive the Market
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Drug Class
      • 5.1.1. Prophylaxis
      • 5.1.2. Treatment
    • 5.2. Market Analysis, Insights and Forecast - by End-user
      • 5.2.1. Hospital Pharmacy
      • 5.2.2. Retail Pharmacy
      • 5.2.3. Online Pharmacy
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. By Geography
  6. 6. North America Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 6.1. Market Analysis, Insights and Forecast - By Drug Class
        • 6.1.1. Prophylaxis and Treatment
      • 6.2. Market Analysis, Insights and Forecast - By End-user
        • 6.2.1 Hospital Pharmacy
        • 6.2.2 Retail Pharmacy
        • 6.2.3 and Online Pharmacy
      • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 6.3.1 United States
        • 6.3.2 Canada
        • 6.3.3 Mexico
  7. 7. South America Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 7.1. Market Analysis, Insights and Forecast - By Drug Class
        • 7.1.1. Prophylaxis and Treatment
      • 7.2. Market Analysis, Insights and Forecast - By End-user
        • 7.2.1 Hospital Pharmacy
        • 7.2.2 Retail Pharmacy
        • 7.2.3 and Online Pharmacy
      • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 7.3.1 Brazil
        • 7.3.2 Argentina
        • 7.3.3 Rest of South America
  8. 8. Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 8.1. Market Analysis, Insights and Forecast - By Drug Class
        • 8.1.1. Prophylaxis and Treatment
      • 8.2. Market Analysis, Insights and Forecast - By End-user
        • 8.2.1 Hospital Pharmacy
        • 8.2.2 Retail Pharmacy
        • 8.2.3 and Online Pharmacy
      • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 8.3.1 Germany
        • 8.3.2 France
        • 8.3.3 Italy
        • 8.3.4 United Kingdom
        • 8.3.5 Netherlands
        • 8.3.6 Rest of Europe
  9. 9. Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 9.1. Market Analysis, Insights and Forecast - By Drug Class
        • 9.1.1. Prophylaxis and Treatment
      • 9.2. Market Analysis, Insights and Forecast - By End-user
        • 9.2.1 Hospital Pharmacy
        • 9.2.2 Retail Pharmacy
        • 9.2.3 and Online Pharmacy
      • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 9.3.1 China
        • 9.3.2 Japan
        • 9.3.3 India
        • 9.3.4 South Korea
        • 9.3.5 Taiwan
        • 9.3.6 Australia
        • 9.3.7 Rest of Asia-Pacific
  10. 10. MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 10.1. Market Analysis, Insights and Forecast - By Drug Class
        • 10.1.1. Prophylaxis and Treatment
      • 10.2. Market Analysis, Insights and Forecast - By End-user
        • 10.2.1 Hospital Pharmacy
        • 10.2.2 Retail Pharmacy
        • 10.2.3 and Online Pharmacy
      • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 10.3.1 Middle East
        • 10.3.2 Africa
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2023
      • 11.2. Company Profiles
        • 11.2.1 AstraZeneca (U.K)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Bausch Health Companies Inc. (U.S)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 AbbVie (U.S)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Johnson and Johnson Services Inc. (U.S)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Sanofi (France)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Merck & Co. Inc. (U.S)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Celltrion Inc. (South Korea)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 mAbxience (Spain)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Enanta Pharmaceuticals Inc (U.S)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Breakdown (USD million, %) by Region 2023 & 2031
  2. Figure 2: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  3. Figure 3: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  4. Figure 4: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Forecast (USD million), by Prophylaxis 2020 & 2031
  5. Figure 5: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Forecast (USD million), by Treatment 2020 & 2031
  6. Figure 6: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  7. Figure 7: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  8. Figure 8: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Forecast (USD million), by Hospital Pharmacy 2020 & 2031
  9. Figure 9: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Forecast (USD million), by Retail Pharmacy 2020 & 2031
  10. Figure 10: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Forecast (USD million), by Online Pharmacy 2020 & 2031
  11. Figure 11: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Region 2023 & 2031
  12. Figure 12: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Region 2023 & 2031
  13. Figure 13: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  14. Figure 14: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  15. Figure 15: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  16. Figure 16: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  17. Figure 17: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  18. Figure 18: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  19. Figure 19: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  20. Figure 20: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  21. Figure 21: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  22. Figure 22: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  23. Figure 23: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  24. Figure 24: South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  25. Figure 25: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  26. Figure 26: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  27. Figure 27: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  28. Figure 28: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  29. Figure 29: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  30. Figure 30: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  31. Figure 31: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  32. Figure 32: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  33. Figure 33: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  34. Figure 34: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  35. Figure 35: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  36. Figure 36: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  37. Figure 37: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  38. Figure 38: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  39. Figure 39: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  40. Figure 40: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  41. Figure 41: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  42. Figure 42: MEA Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  43. Figure 43: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Drug Class 2023 & 2031
  44. Figure 44: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  45. Figure 45: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by End-user 2023 & 2031
  46. Figure 46: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by End-user 2023 & 2031
  47. Figure 47: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million), by Country 2023 & 2031
  48. Figure 48: By Geography Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  2. Table 2: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  3. Table 3: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Region 2018 & 2031
  4. Table 4: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  5. Table 5: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  6. Table 6: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Region 2018 & 2031
  7. Table 7: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  8. Table 8: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  9. Table 9: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  10. Table 10: United States Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  11. Table 11: Canada Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  12. Table 12: Mexico Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  13. Table 13: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  14. Table 14: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  15. Table 15: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  16. Table 16: Brazil Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  17. Table 17: Argentina Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  18. Table 18: Rest of South America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  19. Table 19: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  20. Table 20: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  21. Table 21: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  22. Table 22: Germany Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  23. Table 23: France Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  24. Table 24: Italy Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  25. Table 25: United Kingdom Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  26. Table 26: Netherlands Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  27. Table 27: Rest of Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  28. Table 28: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  29. Table 29: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  30. Table 30: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  31. Table 31: China Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  32. Table 32: Japan Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  33. Table 33: India Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  34. Table 34: South Korea Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  35. Table 35: Taiwan Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  36. Table 36: Australia Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  37. Table 37: Rest of Asia-Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  38. Table 38: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  39. Table 39: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  40. Table 40: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  41. Table 41: Middle East Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  42. Table 42: Africa Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  43. Table 43: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Drug Class 2018 & 2031
  44. Table 44: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by End-user 2018 & 2031
  45. Table 45: Global Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue USD million Forecast, by Country 2018 & 2031
  46. Table 46: North America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  47. Table 47: Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  48. Table 48: Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  49. Table 49: Latin America Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
  50. Table 50: Middle East & Africa Respiratory Syncytial Virus (RSV) Therapeutics Market Revenue (USD million) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 21.2% from 2018-2032
Segmentation
    • By Drug Class
      • Prophylaxis
      • Treatment
    • By End-user
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
  • By Geography
    • By Geography
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...